期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | ENDOCRINE JOURNAL LetPub Score 5.3
50 ratings
Rate
Reputation 5.9 Influence 3.9 Speed 9.1 | ||||||||||||||||||||
期刊簡稱 | ENDOCR J | ||||||||||||||||||||
ISSN | 0918-8959 | ||||||||||||||||||||
E-ISSN | 1348-4540 | ||||||||||||||||||||
h-index | 65 | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 0.00%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | https://www.jstage.jst.go.jp/browse/endocrj/ | ||||||||||||||||||||
在線稿件提交 | https://mc.manuscriptcentral.com/endocrj | ||||||||||||||||||||
開放訪問 | Yes | ||||||||||||||||||||
出版商 | Japan Endocrine Society | ||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||
出版國/地區 | JAPAN | ||||||||||||||||||||
發行頻率 | 隔月刊行 | ||||||||||||||||||||
創刊年 | 1993 | ||||||||||||||||||||
每年文章數 | 154每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 98.35% | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q4
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0918-8959%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 1.5 Month(s) | ||||||||||||||||||||
競爭力 * | 來自作者的數據: About 75% | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 3 4 下一頁 末頁 (頁 | |
[ENDOCRINE JOURNAL] 的評論 | 撰寫評論 |
作者: 宗室念凡 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-06 12:47:09 評論於 Do you have any updates on your review in progress?(0) 讚! | 宗室念凡 |
作者: 长安靖蕊 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-15 11:42:47 評論於 Is there a layout fee, or are there any other charges besides the layout fee?(0) 讚! | 长安靖蕊 |
作者: 奉天祺祥 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-07 21:31:09 評論於 Review Speed: 1.0 Emphasis on Research Direction: Endocrinology Experience Shared: The article on pharmacology took one month for the first review, but the feedback from both reviewers was not favorable. Due to lack of novelty, the article was rejected(0) 讚! | 奉天祺祥 |
作者: 奉天祺祥 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-02-28 18:16:29 評論於 Hello, may I ask how long the review process for your submission usually takes?(0) 讚! | 奉天祺祥 |
作者: 奉天祺祥 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-02-28 12:16:14 評論於 Hello, how long does it take for your manuscript to change to the "review in process" status?(0) 讚! | 奉天祺祥 |
作者: 奉天祺祥 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-02-09 13:48:44 評論於 To preview PDF files(0) 讚! | 奉天祺祥 |
作者: 东风优悠 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-26 19:30:24 評論於 What kind of article are you looking for?(0) 讚! | 东风优悠 |
作者: 东风优悠 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-26 15:01:03 評論於 What type of article is this?(0) 讚! | 东风优悠 |
作者: 梓玥小仙女 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-09-21 12:25:00 評論於 Hello, can I ask you about a formatting issue?(0) 讚! | 梓玥小仙女 |
作者: 先天水之 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-06-27 08:37:50 評論於 Excuse me, after clicking "Submit" on the last step of the submission system, it just goes to a black screen and won't submit. What's going on?(0) 讚! | 先天水之 |
作者: Moira Rhys 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-06-22 15:24:54 評論於 Have you solved it? Do we need to upload the color certificate?(0) 讚! | Moira Rhys |
作者: Louise Jane 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-04-19 23:00:16 評論於 It is common practice for editing agencies to provide certification for their editing services(0) 讚! | Louise Jane |
作者: 中原文仙 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-04-14 22:15:58 評論於 How did you get your certificate polished?(0) 讚! | 中原文仙 |
作者: 紫霞清梅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-04-13 15:45:29 評論於 Does this journal provide recommended editing services?(0) 讚! | 紫霞清梅 |
作者: 紫霞清梅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-04-13 14:21:07 評論於 Should I find an organization to edit my paper or will the journal recommend one?(0) 讚! | 紫霞清梅 |
作者: 中原文仙 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-04-12 14:58:33 評論於 How to get a certificate of proofreading? Are you going to find an organization to proofread it yourself?(0) 讚! | 中原文仙 |
作者: 无相佩珍 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-04-12 11:15:53 評論於 How is this journal?(0) 讚! | 无相佩珍 |
作者: 无相佩珍 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-04-12 10:21:45 評論於 Where is my review?(0) 讚! | 无相佩珍 |
作者: 无相佩珍 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-04-09 18:48:56 評論於 Review speed: 3.0 | Submission success rate: 25.0 Emphasized research direction: endocrinology Experience sharing: The waiting process is long, as taught by other teachers, but it will get faster later on(0) 讚! | 无相佩珍 |
作者: 深渊卫杰 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-03-24 12:46:28 評論於 I can't register. How to register?(0) 讚! | 深渊卫杰 |
作者: 七星新筠 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-03-22 18:31:45 評論於 There is none(0) 讚! | 七星新筠 |
作者: 墟散玉韵 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-02-15 08:49:38 評論於 Review speed: 2.0 | Submission acceptance rate: 75.0 Sharing experience: Submitted to acceptance in 42 days, underwent a major revision, and the editor and reviewers all seemed quite friendly. Hope to break 3 next year(0) 讚! | 墟散玉韵 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 21:08:46 評論於 Yes(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 20:58:18 評論於 There may not be only one corresponding author for a paper published in an SCI journal, and there is no fixed standard for how many there can be. This is because different SCI journals have different policies regarding the number of corresponding authors. For SCI journals that only acknowledge one corresponding author, if a paper lists multiple corresponding authors, the first corresponding author will be automatically selected. For SCI journals that acknowledge two corresponding authors, two corresponding authors can be listed. The same applies to other requirements. In other words, the number of corresponding authors listed by the authors must comply with the regulations of the target SCI journal. The first author of an SCI paper is the person who has made the greatest contribution to the experimentation and writing of the paper and is the person listed first in the authors' list. However, in cases of collaboration involving multiple authors, there may be joint first authors. There is no specific regulation regarding the number of joint first authors, and this is greatly influenced by factors such as the workload and length of the paper, the regulations of the publishing journal, and the recognition by the institution. Generally, 2-4 first authors are most common for an SCI paper(0) 讚! | 维尔娜菲茨杰拉德 |
作者: Oswald Edie 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 09:57:38 評論於 Will all authors receive an email after the article is accepted?(0) 讚! | Oswald Edie |
首頁 上一頁 1 2 3 4 下一頁 末頁 (頁 |
Contact us